Navigation Links
Three Prize Winners Awarded in Elsevier's Article 2.0 Contest
Date:3/31/2009

AMSTERDAM, March 31 /PRNewswire-FirstCall/ --

- "Thinking Outside the Box" Yields web 3.0, Nonlinear and Smartphone Applications

Elsevier, a leading global healthcare and scientific publisher, has announced the winners in the Elsevier Article 2.0 Contest ( http://www.article20.elsevier.com), a competition challenging individuals to develop creative and useful solutions for rendering journal articles on the web. The contest attracted interest from contestants across the globe with submissions including web, mobile and desktop applications. The panel of seven distinguished judges, drawn from academia, publishing, policymaking and media, considered how each application improved on the existing online presentation of research articles. Special attention was paid to contestants' ability to 'think outside of the box' as well as ease of use and the overall quality of the application.

The $4,000 first prize was awarded to Inigo Surguy whose idea demonstrated how Web 1.0, Web 2.0 and Web 3.0/Semantic Web approaches can be combined to add value to article content. His application enhances content navigation, facilitating commentary on specific paragraphs, and assertions about the article and its contents.

The $2,000 second prize was awarded to Jacek R. Ambroziak. His mobile application enables reading Elsevier articles on an Android Smartphone. Stuart Chalk, the $1000 third prize winner, submitted an idea operating on the premise that research articles are inherently non-linear and that researchers view articles in a random fashion, depending on their interests.

"It is exciting to see the article beginning to emerge as a real digital artefact, using XML to create more than just an enhancement of the print version, and addressing the problems of different digital distribution channels like mobile for the first time," remarked David R. Worlock, Chief Research Fellow, Outsell Inc., and one of the seven Article 2.0 Contest Judges, " But these are just the first steps in what will ultimately be a complete redesign of scholarly communication in the networks."

The panel of Article 2.0 judges also included: Alan Darnell, Manager of the Scholars Portal Project; Dave Kellogg, Chief Executive Officer of MarkLogic; Dr. Donald Lindberg, Director of the National Library of Medicine; Jill O'Neil, Director, Planning and Communication, National Federation of Abstracting and Information Services; Andrew Perry, Postdoctoral Researcher of the University of Melbourne; and Rafael Sidi, Vice President of Product Management, ScienceDirect, Elsevier.

"The Article 2.0 Contest has been another opportunity for Elsevier to collaborate with researchers and developers by providing the building blocks to achieve innovative outcomes", said Darin McBeath, Director of Disruptive Technologies, based in Cincinnati, Ohio.

This initiative reflects Elsevier's goal of getting closer to customers and delivering innovative online tools to increase productivity. Another key innovation contest, The Elsevier Grand Challenge: Knowledge Enhancement in the Life Sciences (http://www.elseviergrandchallenge.com) will be announcing its Grand prize winners from among four finalists at the Experimental Biology Meeting (http://www.eb2009.org) on April 21st. These winners promise new ways of enhancing deep value in scientific content. Over the course of the past year, the Grand Challenge has invited members of the scientific community to describe and prototype tools to improve the interpretation and identification of meaning in online journals and text databases relating to the life sciences.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Anna Hogrebe
    Tel: +31-20-485-3269
    newsroom@elsevier.com

   Contact:  Anna Hogrebe, Tel: +31-20-485-3269, newsroom@elsevier.com

'/>"/>
SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Oncology Wins Three National Safety Council Awards
2. Three New Trustees Named By March of Dimes Foundation
3. Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists
4. Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit
5. Three New NextCare Immediate Care Clinic Locations Open in Colorado
6. Leader in Health Plan Cost Containment Cites Three Economy-Driven Reasons Why Self-Insured Health Plans Should Brace for Claim Increases and Fund Reserves Accordingly
7. Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing
8. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
9. Living With Grief: Diversity and End-of-Life Care' National Teleconference Offered at Three Bay Area Locations
10. Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
11. Three Cetaphil(R) Products Awarded National Eczema Association Seal of Acceptance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... ... "I have gout, and I wanted to treat it naturally," said an ... relieve gout and pain caused by varicose veins. I drank it every morning for ... what VA doctors called the worst sinusitis case they'd seen and relieved gas, stress ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the ... the grand opening of the Sober College Robert Pfeifer Memorial Learning Center at ... 2-3, and was attended by an overwhelming amount of alumni, family, colleagues and ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest edition ... to sign up as an organ donor for the 123,000 people in the United ... donor can save up to 8 saves through organ donation and enhance many others ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Mitsubishi Tanabe Pharma Corporation (Head Office: ... Dr. Masayuki Mitsuka ) has presented data that ... intravenously in 10-14 day cycles for 48 weeks experienced ... Functional Rating Scale-Revised (ALSFRS-R). The data were presented at ... Dublin, Ireland . In ...
(Date:12/9/2016)... , Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The global travel vaccines market to grow ... The report covers the present scenario and the growth prospects of ... size, the report considers the revenue generated from the sales of ...
(Date:12/9/2016)...  Forge Therapeutics, Inc. today announced a strategic ... TecDAX, ISIN: DE0005664809) to advance its novel Gram-negative ... bacterial infections including those caused by drug resistant ... antibacterial target for more than the past 15 ... points has hampered its progress. Forge has been ...
Breaking Medicine Technology: